Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Presentation TCT India 2025

DAPT in STEMI – Do We Have Clarity on Drug, Dose and Duration?

Presenter: Rishi Sethi

July 26, 2025

Presentation EuroPCR 2024

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Presenter: Ling Tao

May 15, 2024

Presentation Cardiovascular Interventions 2022

OCT GUIDED DES DAPT & LIPID MANGEMENT

Presenter: Richard Shlofmitz

October 28, 2022

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Presentation ARCH 2019

Update on Dual Antiplatelet Therapy

Presenter: James B Hermiller

April 12, 2019

Presentation SIF 2019

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

Presenter: Michael A. Kutcher

March 28, 2019

Presentation JIM 2019

Iatrogenic aortocoronary dissection after routine PCI

Presenter: Pamela Gatto

February 15, 2019

Presentation CIT 2018

PCI in a high bleeding risk patients

Presenter: Tullio Palmerini

March 23, 2018

Presentation Cardiovascular Interventions 2017

DAPT Duration After Stenting: An Updated Appraisal

Presenter: Dean J. Kereiakes

November 09, 2017

Presentation SIF 2017

Debate: With Modern Generation DES, 3 – 6 months of DAPT Is All You Need

Presenter: William B. Bachinsky

March 10, 2017

Presentation JIM 2017

BRS - A “Stillborn” Device!

Presenter: Davide Capodanno

February 08, 2017

Presentation Cardiovascular Interventions 2016

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Presenter: Dean J. Kereiakes

November 10, 2016

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

Presentation JIM 2016

DES safety and DAPT: The Ultimaster DES

Presenter: Corrado Tamburino

February 10, 2016

Presentation JIM 2016

BioFreedom DCS With 1-Month DAPT: The New Standard For High Bleeding Risk Patients

Presenter: Antonio L. Bartorelli

February 10, 2016

Presentation

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Presenter: D. J. Kereiakes

March 24, 2015

Presentation

SECURITY: Second-Generation DES Implantation Followed by 6- vs 12-Month DAPT

Presenter: Antonio Colombo

November 10, 2014

Advertisement

DAPT in STEMI – Do We Have Clarity on Drug, Dose and Duration?

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

OCT GUIDED DES DAPT & LIPID MANGEMENT

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Update on Dual Antiplatelet Therapy

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

Iatrogenic aortocoronary dissection after routine PCI

PCI in a high bleeding risk patients

DAPT Duration After Stenting: An Updated Appraisal

Debate: With Modern Generation DES, 3 – 6 months of DAPT Is All You Need

BRS - A “Stillborn” Device!

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Timing of DAPT Interruption and DES Thrombosis

Optimal Duration of DAPT: Update on DAPT Guidelines

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

DES safety and DAPT: The Ultimaster DES

BioFreedom DCS With 1-Month DAPT: The New Standard For High Bleeding Risk Patients

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

SECURITY: Second-Generation DES Implantation Followed by 6- vs 12-Month DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content